Figure-1 (Figure 1)
Guanfacine Extended-release Tablet, Extended Release
Product Images NDC 71335-2852
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine Extended-release (NDC 71335-2852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2 (Figure 2)
This is a list showing the change in area under the curve (AUC) due to CYP3A4 inhibitors and inducers. It includes human data for ketoconazole, rifampin, oral methylphenidate, and lisdexamfetamine dimesylate, as well as computer simulations for fluconazole and efavirenz. The data provides information on the fold change and 90% confidence intervals for each substance relative to a reference point.*
Figure-3 (Figure 3)
Figure4.jpg (Figure4)
Label (Lbl713352852)
This text appears to be a package insert for guanfacine hydrochloride tablets containing 2 mg of guanfacine. The tablets should not be crushed, chewed, or broken before swallowing. It also provides storage instructions and dosage information.*
Spd503-chemical-stucture (Spd503 Chemical Stucture)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
